Written by the Editor
Metrion Biosciences is open to discuss your ion channel drug discovery and safety profiling requirements via email@example.com.
In response to the global COVID-19 outbreak, and to help us to safeguard the health and safety of our employees and their families, we temporarily closed our laboratories in April 2020 as advised by the UK Government. After making significant changes to our laboratory space and work patterns we recommenced laboratory operations on 4th May 2020 and the team is back at Granta Park providing high quality ion channel screening services to our customers.
To help us maintain responsible levels of social distancing some of our team are operating from home, they can be contacted at firstname.lastname@example.org and will be happy to help.
We would like to thank our customers for their support at this unprecedented time and our team looks forward to providing data to drive customer drug discovery projects forward during this challenging period for all of us.